1,295 results on '"Costanzo, Antonio"'
Search Results
152. Compact Slotted Antenna for Wideband Radar Applications
153. High Resolution Software Defined Radar System for Target Detection
154. Geotechnical Aspects of the L’Aquila Earthquake
155. NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas
156. ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases
157. OSCI-LIGHT: Oscillators based Synchronization for Visible Light Communication Systems
158. Laser Scanning Investigation and Geophysical Monitoring to Characterise Cultural Heritage Current State and Threat by Traffic-Induce Vibrations: The Villa Farnesina in Rome
159. 3 years of tralokinumab treatment provides long-term disease control as demonstrated by clinically meaningful outcomes in moderate-to-severe atopic dermatitis
160. Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest
161. Cutaneous localisation of Hodgkin lymphoma resembling hard-to-heal graft-versus-host disease skin ulcers: a tricky mimic
162. Neuropsychological correlates of theory of mind in chronic migraine.
163. Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report
164. Long-term improvements in disease severity, itch, and QoL after 3 years of tralokinumab treatment in adults with moderate-to-severe AD
165. Monkeypox infection with perianal lesions, fever, and lymphadenopathy
166. Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study— IL PSO ( Italian landscape psoriasis )
167. ESDR365 - Secukinumab normalizes skin transcriptomes to a never-lesional state in new-onset psoriasis patients more rapidly than in chronic patients
168. ESDR417 - Dupilumab Significantly Improves Sleep Disturbance in Adults with Moderate-to-Severe Atopic Dermatitis: Results of the DUPISTAD study
169. Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75%
170. 33298 Long-term safety and efficacy of tralokinumab in more than 1400 moderate-to-severe atopic dermatitis patients treated for up to 42 months: An interim analysis of ECZTEND
171. 52667 Tildrakizumab improves sleep quality, quality of life and work productivity in patients with moderate-to-severe plaque psoriasis in conditions close to real clinical practice
172. 52660 Tildrakizumab improves sleep quality and psoriasis-related pruritus and pain in patients with moderate-to-severe plaque psoriasis in conditions close to real clinical practice
173. 51202 Effectiveness of Biologics in Clinical Practice: Interim Month 24 Results from the International Observational Psoriasis Study of Health Outcomes (PSoHO)
174. 53999 Efficacy and safety after 52 weeks in psoriasis patients switching to risankizumab after suboptimal response to secukinumab or ixekizumab – a subgroup analysis
175. 51042 Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma.
176. 52685 Bimekizumab efficacy and safety through 4 years in moderate to severe plaque psoriasis: Long-term results from the BE SURE trial and BE BRIGHT open-label extension
177. 54218 Achievement of high NPF treatment targets after 52 weeks in psoriasis patients switching to risankizumab after suboptimal response to secukinumab or ixekizumab
178. Paradoxical Psoriasis: From its Many Faces to Possible Shared Therapeutic Targets
179. A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks.
180. Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes ( PSoHO )
181. An Interference to Noise Ratio Handover mechanism for Mobile Visible Light Communication Networks
182. Project R. Evolution for improving clinical research in Italy: challenges and strategies
183. An apparent primitive mass of the mesentery
184. Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italian landscape psoriasis)
185. Urban Seismic Network Based on MEMS Sensors: The Experience of the Seismic Observatory in Camerino (Marche, Italy)
186. Adaptive Energy Saving Technique with Saturation Avoidance for Outdoor VLC
187. Early predictors of psoriatic arthritis: a Delphi-based consensus from Italian dermatology centers
188. INVISIBLE: Enhanced Handover technique for Vehicular Visible Light Networks
189. Project R. Evolution for improving clinical research in Italy: challenges and strategies
190. European consensus statement on phenotypes of pustular psoriasis
191. The first Urban Seismic Observatory based on MEMS accelerometers in central Italy : The INGV (Istituto Nazionale di Geofisica e Vulcanologia) experience of Rende and ONT (Osservatori Nazionale terremoti) Sicilia in ARCH project
192. The biological basis of disease recurrence in psoriasis: a historical perspective and current models
193. The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender Perspective
194. Seismic behaviour and 3D reconstruction of Cultural Heritage: the Column of the Hera Lacinia Temple in Capo Colonna (Calabria, Southern Italy)
195. Traffic-induced vibrations on cultural heritage in urban area: the case of Villa Farnesina in Rome
196. What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
197. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis
198. Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results
199. Empirical Model for the Design of Printed Butterfly Antennas
200. Environmental Effects on the Performances of a UHF Passive Tag-Based Commercial RFID System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.